Journal of Global Antimicrobial Resistance

Scope & Guideline

Connecting researchers to tackle the resistance crisis.

Introduction

Welcome to your portal for understanding Journal of Global Antimicrobial Resistance, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2213-7165
PublisherELSEVIER SCI LTD
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2013 to 2024
AbbreviationJ GLOB ANTIMICROB RE / J. Glob. Antimicrob. Resist.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address125 London Wall, London EC2Y 5AS, ENGLAND

Aims and Scopes

The Journal of Global Antimicrobial Resistance focuses on the multifaceted issues surrounding antimicrobial resistance (AMR), integrating clinical, microbiological, and epidemiological perspectives. The journal aims to disseminate significant findings that contribute to understanding, monitoring, and combating AMR on a global scale.
  1. Epidemiology of Antimicrobial Resistance:
    Research on the prevalence and distribution of antimicrobial resistance across various pathogens, particularly in clinical settings and community health.
  2. Mechanisms of Resistance:
    Investigations into the genetic and biochemical mechanisms underlying resistance to antibiotics and other antimicrobial agents.
  3. Therapeutic Strategies:
    Studies on novel therapeutic approaches, including the use of combination therapies, phage therapy, and new antibiotic classes to combat resistant infections.
  4. Public Health Implications:
    Analysis of the impact of antimicrobial resistance on public health, including infection control measures, antimicrobial stewardship programs, and policy recommendations.
  5. Global Surveillance and Monitoring:
    Reports and studies focusing on global trends in antimicrobial resistance, including data collection and analysis from various regions.
  6. Environmental and One Health Perspectives:
    Research exploring the relationship between antimicrobial resistance in environmental contexts and its implications for human and animal health.
Recent publications in the Journal of Global Antimicrobial Resistance reveal emerging trends and themes that reflect the current challenges and innovations in addressing antimicrobial resistance.
  1. Mobile Genetic Elements:
    There is a notable increase in research focusing on mobile genetic elements (e.g., plasmids, integrons) that facilitate the spread of resistance genes among bacterial populations.
  2. Phage Therapy:
    Growing interest in phage therapy as a potential alternative treatment for antibiotic-resistant infections, with several studies exploring its efficacy and practical applications.
  3. Multidrug-Resistant Organisms:
    A significant rise in studies addressing the characteristics, epidemiology, and treatment options for multidrug-resistant organisms, particularly concerning Klebsiella pneumoniae and Acinetobacter species.
  4. Environmental Resistance Studies:
    Emerging research examining the role of the environment in the dissemination of antimicrobial resistance, including studies on wastewater and agricultural runoff.
  5. AI and Computational Models:
    An increasing trend towards utilizing artificial intelligence and computational models to predict resistance patterns and optimize treatment strategies.
  6. Combination Therapy Approaches:
    Heightened focus on combination therapies, particularly those involving novel agents or repurposed drugs, as a strategy to combat resistant infections.

Declining or Waning

As the journal has evolved, certain themes have seen a decline in publication frequency, reflecting shifting research interests and priorities in the field of antimicrobial resistance.
  1. Non-Bacterial Infections:
    Research focusing on non-bacterial infections, such as viral or fungal pathogens, has become less prominent, possibly due to the increased focus on bacterial resistance issues.
  2. Traditional Antibiotic Susceptibility Testing Methods:
    Studies emphasizing conventional methods of susceptibility testing are waning as newer techniques, such as genomic and metagenomic approaches, gain traction.
  3. Single-Agent Therapy Studies:
    Research focused solely on single-agent therapies for resistant infections is decreasing in favor of studies exploring combination therapies or novel treatments.
  4. Antimicrobial Resistance in Veterinary Medicine:
    While still important, the frequency of studies specifically addressing antimicrobial resistance in veterinary contexts appears to be declining in the journal's recent publications.
  5. Regional Specificity:
    Papers centered on localized resistance patterns in specific countries or regions, without a broader global context, are less frequently published, signaling a shift towards more comprehensive global studies.

Similar Journals

Reviews and Research in Medical Microbiology

Delivering High-Impact Research for Healthcare Professionals
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2770-3150Frequency: 4 issues/year

Reviews and Research in Medical Microbiology is a premier academic journal published by LIPPINCOTT WILLIAMS & WILKINS, focusing on groundbreaking research and comprehensive reviews that advance the understanding of medical microbiology. With an ISSN of 2770-3150 and an E-ISSN of 2770-3169, this journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of pathogens, infectious diseases, and microbial mechanisms affecting health. While the journal currently does not offer open access, its rigorous peer-review process ensures that only high-quality, impactful research is disseminated to the scientific community. The journal aims to bridge gaps in knowledge by presenting cutting-edge studies that explore novel therapeutic strategies, diagnostic methods, and the evolving landscape of microbial resistance. Nestled in the heart of Philadelphia, this journal proudly contributes to the advancement of medical microbiology and is an indispensable platform for the publication of critical findings that shape clinical practices and research trajectories in the field.

Journal of the Pediatric Infectious Diseases Society

Empowering professionals with vital research and insights.
Publisher: OXFORD UNIV PRESSISSN: 2048-7193Frequency: 4 issues/year

Journal of the Pediatric Infectious Diseases Society, published by Oxford University Press, stands as a pivotal platform for advancing knowledge in the realm of pediatric infectious diseases. With an ISSN of 2048-7193 and an E-ISSN of 2048-7207, this esteemed journal has garnered significant recognition in the academic community, achieving influential rankings such as Q1 in Pediatrics, Perinatology and Child Health and Q2 in Infectious Diseases. With converged years from 2012 to 2024, it aims to publish cutting-edge research, reviews, and clinical practices that address the challenges and innovations in the field. The journal's strong performance, reflected in its Scopus ranks (33rd percentile in Pediatrics and 97th in Infectious Diseases), underscores its impact on the global healthcare landscape. As a non-open access journal, it provides exclusive content essential for researchers, medical professionals, and students dedicated to enhancing pediatric healthcare outcomes.

International Journal of Microbiology

Transforming Microbiology Research into Global Impact
Publisher: HINDAWI LTDISSN: 1687-918XFrequency: 1 issue/year

Welcome to the International Journal of Microbiology, a premier platform dedicated to the dissemination of cutting-edge research in the field of microbiology. Published by HINDAWI LTD, this open-access journal has been making significant strides since its inception in 2009, ensuring that high-quality research is accessible to all. Situated in Egypt, the journal caters to an international audience, fostering collaboration across borders. With a commendable impact factor and recognized in the Q2 category for both general and medical microbiology, it ranks 48th out of 182 and 40th out of 140, respectively, according to Scopus statistics, placing it among the top-tier journals in its field. The International Journal of Microbiology publishes articles that explore various aspects of microbiology, from fundamental studies to applied research, thus contributing significantly to advancements in medical, agricultural, and environmental microbiology. This journal is an essential resource for researchers, professionals, and students eager to stay at the forefront of microbiological studies and their applications.

Current Infectious Disease Reports

Pioneering Insights for a Healthier Tomorrow
Publisher: SPRINGERISSN: 1523-3847Frequency: 12 issues/year

Current Infectious Disease Reports, published by SPRINGER, is a leading journal dedicated to advancing knowledge in the field of infectious diseases. With an ISSN of 1523-3847 and an E-ISSN of 1534-3146, this peer-reviewed journal has established itself as a vital resource for researchers and healthcare professionals since its inception in 1999. The journal's impact in the academic community is underscored by its Q1 ranking in Infectious Diseases for 2023, placing it in the top quartile of influential journals in the field. Furthermore, it holds a respectable position at rank #95 out of 344 in the Scopus database, reflecting its substantial contribution to medicine and public health. While currently not an open access journal, it offers a wealth of articles covering the latest research, case studies, and reviews, making it an indispensable tool for those aiming to stay at the forefront of infectious disease science. As we navigate an era marked by emerging and re-emerging infectious threats, Current Infectious Disease Reports remains committed to providing high-quality, relevant research that supports evidence-based practice and informs future studies globally.

EMERGING INFECTIOUS DISEASES

Uncovering Insights to Combat Emerging Health Threats
Publisher: CENTERS DISEASE CONTROL & PREVENTIONISSN: 1080-6040Frequency: 12 issues/year

Emerging Infectious Diseases, published by the Centers for Disease Control and Prevention, is a leading open-access journal that has been dedicated to the field of epidemiology, infectious diseases, and medical microbiology since its inception in 1995. With an impressive impact factor placing it in the Q1 quartile rankings for multiple categories including Epidemiology, Infectious Diseases, and Medical Microbiology, this journal serves as a vital resource for researchers, practitioners, and students dedicated to combating the challenges posed by emerging infectious diseases. The journal's distinguished Scopus ranks further highlight its global influence, ranking #10 in Epidemiology, #26 in Infectious Diseases, and #13 in Medical Microbiology, all within the top percentiles. Accessible and targeted, Emerging Infectious Diseases publishes seminal research and reviews that contribute to the understanding and management of infectious diseases, ensuring that critical insights reach a broad audience. The journal encourages contributions that advance the scientific community’s knowledge and responses to public health challenges.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Transforming Therapeutics for a Healthier Tomorrow
Publisher: AMER SOC MICROBIOLOGYISSN: 0066-4804Frequency: 12 issues/year

Antimicrobial Agents and Chemotherapy, published by the American Society for Microbiology, is a leading journal in the fields of Infectious Diseases and Pharmacology. With a rich history dating back to its inception in 1963, this esteemed journal provides a vital platform for the dissemination of innovative research and advances in antimicrobials and therapeutic strategies. Currently holding a remarkable Q1 ranking in multiple categories, including Infectious Diseases and Pharmacology (medical), the journal occupies a prestigious position within its discipline, supported by exceptional rankings in Scopus metrics. As an essential resource for researchers, professionals, and students alike, it aims to foster knowledge exchange and inspire new strategies in combating infectious diseases. While not an open-access journal, it remains influential in shaping clinical applications and public health strategies through its rigorous peer-reviewed publications.

Infectious Diseases and Clinical Microbiology

Uniting scholars to combat infectious diseases worldwide.
Publisher: DOC DESIGN INFORMATICS CO LTDISSN: 2667-646XFrequency: 4 issues/year

Infectious Diseases and Clinical Microbiology is a pivotal journal dedicated to advancing our understanding of infectious diseases through rigorous scientific research and clinical practices. Published by DOC DESIGN INFORMATICS CO LTD, this journal serves as a vital platform for researchers, healthcare professionals, and students keen on enhancing their knowledge of microbiological sciences and the clinical implications of infectious agents. With an ISSN of 2667-646X, it aims to disseminate significant findings in the field, enriching the scholarly dialogue surrounding infectious diseases. While currently operating under a traditional access model, the journal encourages global collaboration and knowledge sharing, striving to make a meaningful impact in tackling the challenges posed by infectious diseases. Its content aims to bridge the gap between laboratory research and clinical application, making it an essential resource in the contemporary landscape of global health.

Emerging Microbes & Infections

Pioneering discoveries in microbial health.
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 1 issue/year

Emerging Microbes & Infections is a premier open access journal, published by Taylor & Francis Ltd since 2012, dedicated to advancing the understanding of microbial infections and their implications in human health. With an impressive Q1 ranking across multiple categories—including Drug Discovery, Epidemiology, Immunology, and Infectious Diseases—this journal is at the forefront of research in the microbiological sciences. Covering a diverse range of topics, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal's commitment to open access ensures worldwide dissemination of cutting-edge findings, fostering collaboration and innovation in tackling challenges posed by emerging infections. As part of the thriving academic community in the United Kingdom, Emerging Microbes & Infections plays a crucial role in shaping the future of infectious disease research and public health.

Infektsiya i Immunitet

Illuminating the path in immunology and infection studies.
Publisher: SANKT-PETERSBURG-NIIEM IMENI PASTERAISSN: 2220-7619Frequency: 4 issues/year

Infektsiya i Immunitet, published by the esteemed SANKT-PETERSBURG-NIIEM IMENI PASTERA, is a prominent open access journal that has been disseminating vital research findings since 2011. Focusing on the fields of immunology and infectious diseases, this journal serves as a critical platform for scholars, professionals, and students in the Russian Federation and beyond. With an ISSN of 2220-7619 and an E-ISSN of 2313-7398, it currently holds a Q4 ranking in 2023 for both Immunology and Infectious Diseases, along with notable quartile standings in related fields. Despite its emerging status, Infektsiya i Immunitet provides valuable insights and contributes to the growing discourse on immunity and infection prevention strategies, making it an essential resource for those invested in advancing knowledge and enhancing public health outcomes. Researchers can conveniently access its wealth of articles and studies that bridge theoretical understanding and practical implications in their respective domains.

Biosafety and Health

Uniting disciplines to tackle pressing health challenges.
Publisher: ELSEVIERISSN: 2096-6962Frequency: 6 issues/year

Biosafety and Health is a leading peer-reviewed journal published by ELSEVIER, dedicated to advancing knowledge and practice in the fields of biotechnology, infectious diseases, microbiology, and public health. With an ISSN of 2096-6962 and an E-ISSN of 2590-0536, this Open Access journal has been accessible to the global research community since 2019, fostering collaboration and innovation from its base in the Netherlands. Ranked Q2 in multiple categories according to the latest metrics, including Biotechnology and Microbiology (medical), it stands as a testament to high-quality, impactful research that influences clinical and environmental practices. The journal has achieved substantial recognition in various medical fields, ranking in the 88th percentile for Public Health, Environmental and Occupational Health, and the 78th percentile for Infectious Diseases. Researchers and practitioners seeking to contribute to this evolving domain are encouraged to submit their findings, as the journal aims to promote interdisciplinary dialogue and address pressing global health challenges.